By applying ROC analysis for sRAGE versus the established heart failure biomarker NTproBNP, we show that sRAGE has comparable diagnostic accuracy and even better performance in the distinction between mild PAH (FC I) and healthy controls. This evidence concerns the gene NPPB and heart failure.